Study objective-The aim was to assess the relative importance of genetic factors in carcinoma of the stomach, colon, rectum, prostate, and bladder in Scottish males.
Cancer has a spectrum of aetiologies. At one extreme are tumours such as retinoblastoma, a substantial proportion of which are hereditary.' At the other are largely non-hereditary tumours, particularly those associated with occupational exposure, such as mesothelioma with asbestos and angiosarcoma of the liver with vinyl chloride.2 Almost all instances of carcinogenesis, however, probably involve a degree of interaction between genotype and the environment, comparable exposure to the same carcinogenic agent causing malignancy in some individuals but not in others. 3 Indeed, 8% of known human genes appear to influence susceptibility or resistance to cancer. 4 Examples of genotype-environment interaction occur among monogenic disorders known primarily for their association with neoplasia, for example increased susceptibility to sunlight induced skin cancer in patients with the autosomal recessive disorder xeroderma pigmentosum and their heterozygous relatives.5 Genetic variation in the response to environmental carcinogens may also be related to metabolic polymorphisms, as shown by the increased risk of smoking induced lung cancer in extensive metabolisers of debrisoquine.6 At the epidemiological level, however, because common genes and common environmental exposure to carcinogens among relatives can both cause familial aggregation of malignant disease, demonstration of a hereditary component in the absence of a known disorder or genetic marker can be demanding, both in terms of study design and resources.
Surnames provide a simple approach, using data that are readily available, which may help to shed light on the genetic contribution to cancer at different sites. This approach allows estimation of the degree of genetic relationship between groups of patients with the same disease in geographically distant locations, thus reducing the confounding of common genes and common environment that plagues conventional family studies. A disadvantage is that many surnames have multiple origins, but the magnitude of any bias can be assessed by a parallel analysis using only rare Bladder  Highland  3826  395  598  323  586  293  Grampian   8927  1116  1329  975  1622  1076  Tayside  7524  1138  1175  737  1246  900  Fife  6671  914  754  547  1083  858  Lothian  14 327  2071  1855  1269  2578  1823  Borders  1842  258  300  239  405  247  Central  5090  586  527  392  764 Using rare surnames only, significance persisted for carcinoma of the prostate. Relative to control deaths only, the median difference was significantly greater than zero only for carcinoma of the prostate using all surnames. Between regions, using all surnames, the median differences for all five cancers were significantly greater than zero using either all controls or control deaths only.
Significance persisted for carcinoma of the colon, rectum, and prostate relative to all controls when the analysis was restricted to rare surnames, but there were no significant differences relative to control deaths when rare surnames were used. Excluding comparisons involving both rare surnames and control deaths, where sample sizes were small, the pattern of median differences between the within region or between region Ri values for cancer cases and controls suggested that the five cancers fall into three different classes. For carcinoma of the colon and prostate, within region and between region differences were, respectively, 14-42% and 10-30% of their median control values. All differences were significantly greater than zero except those for within region Ri for carcinoma of the colon using control deaths or rare surnames. For carcinoma of the stomach and rectum, within region and between region differences were respectively 9-28% and 0-20% of their median control values.
Only one of the six within region differences but five of the six between region differences were significantly greater than zero. For carcinoma of the bladder, the within region and between region differences were, respectively, 0-18% and 5-25% of their median control values. None of the within region differences and two of the three between region differences were significantly greater than zero (table II) . Furthermore, Ri between cancers within regions disclosed some familial association between all cancers except carcinoma of the bladder (table III) . Isonymy among cases of bladder cancer was therefore not only least pronounced but showed relatively little overlap with that among patients suffering from cancer at the other sites.
Within regions, a significantly higher Ri for cancer cases can be taken as evidence of familial factors in the aetiology of malignant disease. Between regions, it suggests that these familial factors are likely to be genetic rather than environmental, the larger number of significant comparisons reflecting the difference in size between the sets of within region and between region Ri values. The results therefore suggest that genetic factors have a role in the aetiology of carcinoma of the colon and prostate and, probably to a lesser extent, in carcinoma of the stomach and rectum. Inherited susceptibility appears to be least important for carcinoma of the bladder.
Cleek'4 has also used surname analysis to investigate the contribution of genetic factors to cancer aetiology. For all five cancers studied here, he found some surnames which occurred more frequently than expected, the greatest number of such surnames occurring in carcinoma of the colon and prostate. Certain surnames were also associated with cancer at more than one site, in keeping with the significantly increased Ri between some cancers within regions found in the present study (table III) .
Using a related but more rigorous approach, Hill '5 was 24 The results of the present study are therefore in agreement with previous findings using other methods. In addition, within region Ri for all cancers combined indicated that familial factors were most important in Highland, Tayside, and Borders regions. In particular, in Highland Region, there was evidence for the importance of familial factors in the aetiology ofcarcinoma ofthe prostate and colon. There was also evidence that particular rare surnames may be associated with cancer in Grampian Region (table IV) . Pairs of regions with high between region Ri (table V) were often those with individually high within region values (table IV), suggesting that pairs of regions with high values are those likely to share genetic factors important in cancer aetiology. For Highland, the high within region but less pronounced between region Ri values may reflect particular familial factors confined to this region.
As in the study of Hill,'5 it is not possible to use the present results to draw inferences of relative risk in the families of cancer patients. It may, however, be feasible to investigate this matter further, either using empirical data from common disorders with known modes of genetic transmission or through computer simulation. Future investigations into the possible contribution of social class differences in surname distribution to isonymy among cancer cases would also seem to be indicated. 
